DEXCOM (UK) INTERMEDIATE HOLDINGS LTD

Company number 10085177 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£732,854

Balance sheet as at 2024-12-31

View full accounts →

What it does

The principal activity of the company in the year under review was as a holding company, whose subsidiaries are engaged in the sale of medical devices directly to patients and customers outside of the United States.

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2016-03-25
Employees
0 (2024 accounts)
Registered office
Suite 4, 7th Floor 50 Broadway, London, United Kingdom, SW1H 0DB
Postcode
SW1H 0DB
Capital
1 USD
Accounts category
Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-03-24
Next due by
2027-04-07
View filing history →

Nature of business (SIC)

  • 74990 Non-trading company

Officers 3 current · 4 resigned

Iskandar MOUSSA Director
Appointed 2023-02-02
Appointed 2023-02-02
Appointed 2019-05-23

View all officers and resignations →

Group structure 2 subsidiaries

Controlled by DEXCOM (UK) LIMITED — since 2016-04-06

From persons-with-significant-control filings on the public register.

Previous registered addresses 1

AddressChanged on
C/O PAUL HASTINGS (EUROPE) LLP, TEN BISHOPS SQUARE EIGHTH FLOOR, LONDON, E1 6EG, UNITED KINGDOM2017-07-17

Among its peers

Top 5%

by shareholders' funds, of 750 similar companies in SW

Trading since 2016.

1,033 companies are registered at this postcode →

Competitors London

This company ranks 22 among non-trading company in London.

Full league table →

The class of 2016

25%

of the 4,186 companies in this sector incorporated in 2016 are still active today; 73% have since been dissolved.

A fact about the year, not a forecast for this company.

Survival rates for every incorporation year →